Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer
– Toward Health Equity Oncology Grant ™ Supports Initiatives to Break the Cycle of Health Inequity –
“Gilead is committed to advancing health equity and supporting these vital patient advocacy organizations working to close gaps in breast cancer care,” said
Breast cancer affects more American women than any other type of cancer, besides skin cancer.1 But due to social, environmental, and economic disparities, people of color are at increased risk of developing or dying from breast cancer.2 In 2023, an estimated 300,000 women will be diagnosed with breast cancer in the
The 2023 funding will support evidence-based interventions that focus on patient navigation and digital/mobile interventions to improve health equity. All 2023 grantees were chosen based on several criteria including their ability to create measurable and sustainable change toward health equity.
THE Oncology Grant builds on Gilead’s 2022 program, which provided
The 2023 THE Oncology Grant awardees include:
- Asociación Latina De Asistencia Y Prevención Del Cáncer De Mama
-
Association of Community Cancer Centers -
Coalition of Blacks Against Breast Cancer -
Family Reach Foundation -
Franklin Square Hospital Center, Inc. -
George Washington University -
Harris County Hospital District Foundation -
Mary Bird Perkins Cancer Center -
New Orleans Musicians Assistance Foundation -
Nueva Vida Inc. -
Patient Advocate Foundation Inc. -
Shanti Project Inc. -
Share Self-Help For Women With
Breast Or Ovarian Cancer, Inc. -
Sharsheret Inc. - Sisters Working It Out NFP
-
St. Vincent Hospital -
Susan G Komen Breast Cancer Foundation -
The Ellie Fund -
UC Davis,
Comprehensive Cancer Center ,Center for Advancing Cancer Health Equity -
Vietnamese American Cancer Foundation -
Virtua Health Foundation, Inc. - Women’s Cancer Care and Research Program (WeCARE) at UC Davis
-
Women’s
Cancer Resource Center -
Young Survival Coalition, Inc.
About
Gilead has promoted equity, particularly healthcare equity, since the company brought its first therapies to the market. Through global partnerships, Gilead’s medicines today reach millions of people in low- and middle-income countries around the world. In
Gilead and the Gilead logo are trademarks of
For more information about Gilead, please visit the company’s website at
www.gilead.com
, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
1 Breast Cancer Statistics.
2 Cancer Disparities. The
3 Key Statistics for Breast Cancer. The
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131006146/en/
public_affairs@gilead.com
public_affairs@gilead.com
Source: